Managing hypertension with combination diuretics and methyldopa in Nigerian Blacks at the primary care level

Clinical Drug Investigation

Volumn 23, Issue 9, 2003, Pages 583-590

  Erhun, W O ^a   Agbani, E O ^a   Bolaji, E E ^b  

^a OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

^b Comprehensive Health Center ^*  (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE PLUS HYDROCHLOROTHIAZIDE; METHYLDOPA;

ADULT; AGED; ANAMNESIS; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DEVICE; DIASTOLIC BLOOD PRESSURE; DIURETIC THERAPY; ESSENTIAL HYPERTENSION; FEMALE; HEALTH CENTER; HEALTH SERVICE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NIGERIA; OUTPATIENT; PATIENT CARE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; TITRIMETRY; VARIANCE;

EID: 0141836245     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200323090-00004     Document Type: Article

References (23)

1. Holzgreve H. Managing the elderly hypertensive patient beyond blood pressure reduction. J Hypertens 1995; 13 Suppl. 2: S103-7
2. Materson BJ, Reda DJ, Cushman WC, et al. Single-drug therapy for hypertension in men: comparison of six antihypertensive agents with placebo. N Engl J Med 1993; 328: 914-21
3. Chrysant SG, Luu TM. Effects of amiloride on arterial pressure and renal function. J Clin Pharmacol 1980; 20: 322-7
4. McKenna TJ, Donohoe JF, Brien TG, et al. Potassium sparing agents during diuretic therapy in hypertension. BMJ 1971; 2: 739-41
5. Chrysant SG, Ganousis L, Chrysant C. Hemodynamic and metabolic effects of hypomagnesemia in spontaneously hypertensive rats. Cardiology 1988; 75: 81-9
6. Altura BM, Altura BT, Ising H, et al. Magnesium deficiency and hypertension: correlation between magnesium deficient diets and microcirculatory changes in situ. Science 1984; 223: I315-7
7. Hall WD, Ferrario CM, Moore MA, et al. Hypertension related morbidity and mortality in south eastern United States. Am J Med Sci 1997; 313: 195-206
8. Saunders E, editor. Cardiovascular disease in Blacks: cardiovascular clinics, Vol. 21, no. 3. Philadelphia (PA): FA Davis Co, 1991
9. Joint National Committee on Prevention, Evaluation of High Blood Pressure.. Sixth report. Arch Intern Med 1997; 157: 2413-46
10. Hypertension Detection and Follow-up Program Cooperation Group. Five year findings of the Hypertension Detection and Follow-up Program: mortality by race-sex and blood pressure levels: a further analysis. J Community Health 1984; 9: 314-27
11. The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Fifth Report. Arch Intern Med 1993; 153: 154-83
12. Guidelines Subcommittee of the World Health Organization-International Society of Hypertension 1999. World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999; 17: 151-83
13. National High Blood Pressure Education Program Working Group. National High Blood Pressure Education Program working group report on hypertension in elderly. Hypertension 1994; 23: 275-85
14. MacMahon S, Rodgers A. The effect of blood pressure reduction in older patients: an overview of five randomized controlled trials in elderly hypertensive. Clin Exp Hypertens 1993; 15: 967-78
15. American Hospital Formulary Service. Thiazide general statement. In: AHFS Drug Information 1999. Bethesda (MD): American Society of Hospital Pharmacists, 1999: 2297-301
16. Moser M. Clinical management of hypertension. 2nd ed. Caddo (OK): Professional Communications, 1997
17. Setaro JF, Black HR. Refractory hypertension. N Engl J Med 1992; 327: 543-7
18. Konstam M, Dracup K, Baker D, et al. Heart failure: evaluation and care of patients with left-ventricular systolic dysfunction. Clinical Practice Guideline No. 11. Rockville (MD): Agency for Health Policy and Research, Public Health Service, US Department of Health and Human Services, 1994 Jun
19. Carter BL. Highlights of the sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Am J Health Syst Pharm 1998; 55:382-8
20. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755-62
21. Braunwald E. Shattuck lecture: cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 1997; 337: 1360-9
22. Berlowitz DR, Ash AS, Hickey EC. et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998; 339: 1957-63
23. Miller NH, Hill M, Kottke T, et al. The multilevel compliance challenge: recommendations for a call to action; a state for health care professionals. Circulation 1997; 95: 1085-90